Advertisement

Topics

Dong-A PharmTech Co. Ltd., Valenta Pharmaceuticals Company Profile

04:06 EDT 17th July 2018 | BioPortfolio

Dong-A PharmTech is a late-stage pharmaceutical company incorporated in Korea, focused on the development and commercialization of udenafil worldwide excluding Korea.


News Articles [485 Associated News Articles listed on BioPortfolio]

Cryptocurrency Company Medadyn Announces The Appointment Of John C. Dong As Chief Financial Officer

As CFO, Mr. Dong will be responsible for overseeing all financial operations. While the company has over $3,000,000in pre-ICO sales commitments, he and his team Read more...

AbbVie Picks Up Dong-A Candidate As It Makes Immuno-Onc Inroads

Dong-A ST has scored a major early success in its inroads into cancer R&D through a sizable immuno-oncology deal with...  

Interview: Dong-A’s Journey To Becoming An Original Drug Developer

Dong-A ST’s Head of Research Taeyoung Yoon talks to Scrip about the leading South Korean pharma’s ambitions to become a...   

Dong-A Ties With NeuroBo For Diabetic Neuropathy, Alzheimer's

Dong-A makes notable progress in botanical drug programs, reaching deals for its diabetic neuropathic pain and Alzheimer's disease drug assets...  

Researchers Discover Gene for Salt Stress Sensitivity in Rice

Early leaf senescence can cause negative effects on rice yield, but the underlying molecular regulation is not fully understood. The bilateral blade senescence 1 (bbs1), an early leaf senescence and s...

Early Leaf Senecence and Salt Stress Response Gene Found in Rice

Early leaf senescence can cause negative effects on rice yield and its regulation is relatively unknown. The team of Dong-Dong Zeng from Zhejiang University in China isolated and studied the bilateral...

OliX Pharmaceuticals receives Clinical Trial Authorization in the UK to initiate Phase I study with OLX10010, an anti-scar RNAi therapeutics

SUWON, South Korea, May 29, 2018 /PRNewswire/ -- OliX Pharmaceuticals Inc., a leading developer of RNA interference (RNAi) therapeutics (CEO: Dong-ki Lee, Ph.D.), announced that it received the Phase ...

Kwang Dong Pharmaceutical Co Ltd 009290 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12032018] Prices from USD $250

SummaryKwang Dong Pharmaceutical Co Ltd Kwang Dong is a drug manufacturer that develops, manufactures and supplies pharmaceuticals, health drinks and supplements. The company's pharmaceutical products...

PubMed Articles [171 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach.

An extensive use of pharmaceuticals and the widespread practices of their erroneous disposal measures have made these products contaminants of emerging concern (CEC). Especially, active pharmaceutical...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Clinical Trials [224 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1329 Associated Companies listed on BioPortfolio]

Dong-A PharmTech Co. Ltd., Valenta Pharmaceuticals

Dong-A PharmTech is a late-stage pharmaceutical company incorporated in Korea, focused on the development and commercialization of udenafil worldwide excluding Korea.

Dong-A PharmTech Co. Ltd.

PharmTech, Inc.

PharmTech, Inc. is a consulting firm providing GMP compliance and validation services to manufacturers in FDA regulated industries. Our consultants provide valuable insight and experience-based knowle...

Dong-A America Corporation

A company's performance is publicly measured by the balance statement but that is not enough. This homepage was made to help you understand the current status of Dong-A Pharmaceutical and what we are ...

Sunny Pharmtech Inc.

Sunny Pharmtech Inc. is an emerging specialty pharmaceutical company based in Taiwan and was founded in 2004 with a focus on the development of technically difficult products. In ...

More Information about "Dong-A PharmTech Co. Ltd., Valenta Pharmaceuticals" on BioPortfolio

We have published hundreds of Dong-A PharmTech Co. Ltd., Valenta Pharmaceuticals news stories on BioPortfolio along with dozens of Dong-A PharmTech Co. Ltd., Valenta Pharmaceuticals Clinical Trials and PubMed Articles about Dong-A PharmTech Co. Ltd., Valenta Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dong-A PharmTech Co. Ltd., Valenta Pharmaceuticals Companies in our database. You can also find out about relevant Dong-A PharmTech Co. Ltd., Valenta Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record